Skip to Content

Mission and Goals


The mission of the Clinical Research Center for Myeloproliferative Neoplasia (MPN) is to identify and develop treatment strategies to effectively treat MPN, prolong patients’ lives, and ultimately cure them of the disease.


The overarching goal of the Clinical Research Center for MPN is to develop a comprehensive approach to understanding the biology of myeloproliferative diseases, leading to the development of new and effective therapies through translational and clinical research. The following objectives are designed to achieve this goal:

  • Conduct clinical trials with novel agents developed specifically for patients with MPN. The center will provide the clinical infrastructure allowing for the conduct of prime clinical research in MPN.
  • Establish a centralized tissue bank for collection of patient samples for translational research and a database for clinical and pathology information.
  • Disseminate information about MPN and educate patients, families, and healthcare providers about the latest treatment and research strategies.

© 2014 The University of Texas MD Anderson Cancer Center